Hartman, Mark L.

Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M. L. (2023) · New England Journal of Medicine

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 1,174

Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis

Loomba, R., Hartman, M. L., Lawitz, E. J., Vuppalanchi, R., Boursier, J., Bugianesi, E., Yoneda, M., Behling, C., Cummings, O. W., Tang, Y., et al. (2024) · New England Journal of Medicine

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 1,005

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Rosenstock, J., Frias, J., Jastreboff, A. M., Du, Y., Lou, J., Gurbuz, S., Thomas, M. K., Hartman, M. L., Haupt, A., Milicevic, Z., et al. (2023) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 423

Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency

Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 423

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

Hartman, M. L., Sanyal, A. J., Loomba, R., Wilson, J. M., Nikooienejad, A., Bray, R., Karanikas, C. A., Duffin, K. L., Robins, D. A., & Haupt, A. (2020) · Diabetes Care

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 351

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

Sanyal, A. J., Kaplan, L. M., Frias, J. P., Brouwers, B., Wu, Q., Thomas, M. K., Harris, C., Schloot, N. C., Du, Y., Mather, K. J., et al. (2024) · Nature Medicine

Liver Disease Diagnosis and TreatmentPharmacology and Obesity Treatment

Cited by 315

Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men

Hartman, M. L. (1992) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsHypothalamic control of reproductive hormones

Cited by 296

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., Ross, T., Bernardo, B., Oldenburger, A., Hjuler, S. T., et al. (2024) · Nature Metabolism

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 262

Thirty-Second Sampling of Plasma Growth Hormone in Man: Correlation with Sleep Stages*

HOLL, R. W., HARTMAN, M. L., VELDHUIS, J. D., TAYLOR, W. M., & THORNER, M. O. (1991) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsHypothalamic control of reproductive hormones

Cited by 239

Gender governs the relationship between exercise intensity and growth hormone release in young adults

Pritzlaff-Roy, C. J., Widemen, L., Weltman, J. Y., Abbott, R., Gutgesell, M., Hartman, M. L., Veldhuis, J. D., & Weltman, A. (2002) · Journal of Applied Physiology

Growth Hormone and Insulin-like Growth FactorsExercise and Physiological Responses

Cited by 87

Exercise training decreases the growth hormone (GH) response to acute constant-load exercise

WELTMAN, A., WELTMAN, J. Y., WOMACK, C. J., DAVIS, S. E., BLUMER, J. L., GAESSER, G. A., & HARTMAN, M. L. (1997) · Medicine & Science in Sports & Exercise

Growth Hormone and Insulin-like Growth FactorsCardiovascular and exercise physiology

Cited by 62

Incretin-based investigational therapies for the treatment of MASLD/MASH

Brouwers, B., Rao, G., Tang, Y., Rodríguez, Á., Glass, L. C., & Hartman, M. L. (2024) · Diabetes Research and Clinical Practice

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 40

The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity

Heerspink, H. J. L., Lu, Z., Du, Y., Duffin, K. L., Coskun, T., Haupt, A., & Hartman, M. L. (2025) · Kidney International Reports

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 23

754-P: Effect of Retatrutide on Kidney Parameters in People with Type 2 Diabetes and/or Obesity—A Post-Hoc Analysis of Two Phase 2 Trials

HEERSPINK, H. L., LU, Z., DU, Y., DUFFIN, K. L., COSKUN, T., HAUPT, A., & HARTMAN, M. L. (2024) · Diabetes

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 7